Pharmaniaga Bhd (XKLS:7081) Equity-to-Asset : -0.13 (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Pharmaniaga Bhd Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pharmaniaga Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2024 was RM-272 Mil. Pharmaniaga Bhd's Total Assets for the quarter that ended in Mar. 2024 was RM2,064 Mil. Therefore, Pharmaniaga Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was -0.13.

The historical rank and industry rank for Pharmaniaga Bhd's Equity-to-Asset or its related term are showing as below:

XKLS:7081' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.2 Med: 0.27 Max: 0.42
Current: -0.13

During the past 13 years, the highest Equity to Asset Ratio of Pharmaniaga Bhd was 0.42. The lowest was -0.20. And the median was 0.27.

XKLS:7081's Equity-to-Asset is ranked worse than
95% of 100 companies
in the Medical Distribution industry
Industry Median: 0.37 vs XKLS:7081: -0.13

Pharmaniaga Bhd Equity-to-Asset Historical Data

The historical data trend for Pharmaniaga Bhd's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaniaga Bhd Equity-to-Asset Chart

Pharmaniaga Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.21

0.20

-0.20

-0.16

Pharmaniaga Bhd Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial															-0.07	-0.07	-0.13	-0.16	-0.13

Competitive Comparison of Pharmaniaga Bhd's Equity-to-Asset

For the Medical Distribution subindustry, Pharmaniaga Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaniaga Bhd's Equity-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Equity-to-Asset falls into.

Pharmaniaga Bhd Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pharmaniaga Bhd's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-299.066	/	1914.854
	=	-0.16

Pharmaniaga Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	-272.109	/	2064.143
	=	-0.13

Pharmaniaga Bhd (XKLS:7081) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Pharmaniaga Bhd Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharmaniaga Bhd's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaniaga Bhd (XKLS:7081) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmaniaga Bhd (XKLS:7081) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, SGR, MYS, 40000

Website

https://www.pharmaniaga.com

Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia and Other countries, of which key revenue is derived from Malaysia.

Pharmaniaga Bhd (XKLS:7081) Headlines

No Headlines